QUOTED. 16 March 2020. Thomas Schinecker.
Roche announced it developed a test for SARS-CoV-2, the virus that causes COVID-19 disease, to run on Roche's cobas 6800 and 8800 molecular testing systems. See what Roche's CEO Thomas Schinecker said about it here.
“Over the last weeks, our emergency response teams have been working hard to bring this test to the patients. CE-mark certification and the FDA’s granting of EUA supports our commitment to give more patients access to reliable diagnostics which are crucial to combat this serious disease.” – Thomas Schinecker, CEO, Roche
Click here for a free trial of Medtech Insight